The Rai system then groups CLL into low (stage 0), intermediate (stages I and II), and high (stages III and IV) risk groups. Here are the stages and what they mean: Stage 0. There are too many white blood cells called lymphocytes in the blood.
CLL and SLL are slow-growing (low-grade or 'indolent') cancers. Many doctors group them together as a type of non-Hodgkin lymphoma. They usually behave like a long-term (chronic) condition that needs treatment from time-to-time to keep it under control.
Stage I: The patient has lymphocytosis and enlarged lymph nodes. The patient does not have an enlarged liver or spleen, anemia, or low levels of platelets. Stage II: The patient has lymphocytosis and an enlarged spleen and/or liver and may or may not have swollen lymph nodes.
There are too many lymphocytes in the blood, but there are no other symptoms of leukemia. Stage 0 is indolent (slow-growing).
Stage 0: The patient has lymphocytosis with more than 5000 lymphocytes per microliter of blood, but no other physical signs. Stage I: The patient has lymphocytosis and enlarged lymph nodes. The patient does not have an enlarged liver or spleen, anemia, or low levels of platelets.
People in stages 0 to II may live for 5 to 20 years without treatment. CLL has a very high incidence rate in people older than 60 years. CLL affects men more than women. If the disease has affected the B cells, the person's life expectancy can range from 10 to 20 years.
Mel Mann was diagnosed with chronic myeloid leukemia and given three years to live — more than 27 years ago. He enrolled in one of the first clinical trials for a drug called Gleevec (imatinib).
Acute myeloid leukemia (AML) is the most fatal type of leukemia. The five-year survival rate (how many people will be alive five years after diagnosis) for AML is 29.5%. Leukemia is a cancer that usually affects white blood cells, though it can start in other types of blood cells.
Like most types of cancers, the earlier you can diagnose and begin treatment for leukemia, the more likely you are to have a successful outcome. However, early symptoms of leukemia can vary depending on the type of leukemia and are often easily confused with other, more common, illnesses.
Life expectancy will depend on a person's age, the type of leukemia, and other factors. For children with acute lymphocytic leukemia (ALL), the 5-year survival rate is now around 90%, according to the American Cancer Society. For other types, however, the chance of living 5 years or more with leukemia may be lower .
Acute lymphocytic leukemia (ALL) 5-year survival rate is 71.3%. Chronic myeloid leukemia (CML) 5-year survival rate is 70.6%. Acute myeloid leukemia (AML) 5-year survival rate is 31.7%. Acute monocytic leukemia (AML-M5) 5-year survival rate is 23.7%.
Many people are diagnosed with CLL even though they do not have any symptoms. The disease may be suspected because of abnormal results from blood tests that were ordered either as part of an annual physical or a medical examination for an unrelated condition.
Even though Stage 0 breast cancer is considered “non-invasive,” it does require treatment, typically surgery or radiation, or a combination of the two. Chemotherapy is usually not part of the treatment regimen for earlier stages of cancer.
Stage 0 breast cancer. Stage 0 breast cancers are often called pre-cancers, pre-invasive cancers or breast carcinoma in situ. With stage 0, abnormal cells in the breast have some cancer characteristics, but they have not yet spread into other tissues or organs.
The 5-year relative survival rate for people age 20 and older is 43%. The 5-year relative survival rate for people under age 20 is 90%. Recent advances in treatment have significantly lengthened the lives of people with ALL. However, the survival rates for the disease vary based on several factors.
Chemotherapy is the major form of treatment for leukemia. This drug treatment uses chemicals to kill leukemia cells. Depending on the type of leukemia you have, you may receive a single drug or a combination of drugs. These drugs may come in a pill form, or they may be injected directly into a vein.
Often referred to as a “silent disease,” CLL can be difficult to diagnose, because people often don't have any symptoms until later in the disease, and others have symptoms that resemble signs of other conditions, such as a cold.
Chronic leukemia often causes only a few symptoms or none at all. Signs and symptoms usually develop gradually. People with a chronic leukemia often complain that they just do not feel well. The disease is often found during a routine blood test.
With CLL , the most common chronic adult leukemia, you may feel well for years without needing treatment.